Turner Kufe

469 total citations
7 papers, 368 citations indexed

About

Turner Kufe is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Turner Kufe has authored 7 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Hematology and 2 papers in Oncology. Recurrent topics in Turner Kufe's work include Glycosylation and Glycoproteins Research (6 papers), Multiple Myeloma Research and Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). Turner Kufe is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Multiple Myeloma Research and Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). Turner Kufe collaborates with scholars based in United States and Israel. Turner Kufe's co-authors include Donald Küfe, David Avigan, Baldev Vasir, Yin Li, Jon Arnason, Rehan Ahmad, Katarina Luptakova, Heidi Mills, Robin Joyce and James D. Levine and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Turner Kufe

7 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Turner Kufe United States	6	216	164	148	128	40	7	368
Irene Manrique Spain	9	206 1.0×	199 1.2×	58 0.4×	151 1.2×	53 1.3×	15	384
YT Tai United States	6	366 1.7×	247 1.5×	90 0.6×	245 1.9×	95 2.4×	10	543
Patricia Balsas Spain	10	290 1.3×	153 0.9×	81 0.5×	133 1.0×	15 0.4×	14	449
Nisha Shah United States	13	230 1.1×	143 0.9×	207 1.4×	174 1.4×	11 0.3×	18	503
Eva Eckelhart Austria	8	175 0.8×	177 1.1×	286 1.9×	248 1.9×	12 0.3×	8	592
R. Rossi United States	5	285 1.3×	318 1.9×	220 1.5×	351 2.7×	28 0.7×	6	681
Bram ten Cate Netherlands	8	239 1.1×	105 0.6×	152 1.0×	44 0.3×	84 2.1×	8	356
Dirk Hönemann Australia	9	202 0.9×	314 1.9×	227 1.5×	121 0.9×	54 1.4×	13	511
Nguyen Tan United States	4	343 1.6×	179 1.1×	48 0.3×	131 1.0×	16 0.4×	7	460
Torsten Steinbrunn Germany	11	348 1.6×	98 0.6×	56 0.4×	211 1.6×	26 0.7×	21	460

Countries citing papers authored by Turner Kufe

Since Specialization

Citations

This map shows the geographic impact of Turner Kufe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Turner Kufe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Turner Kufe more than expected).

Fields of papers citing papers by Turner Kufe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Turner Kufe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Turner Kufe. The network helps show where Turner Kufe may publish in the future.

Co-authorship network of co-authors of Turner Kufe

This figure shows the co-authorship network connecting the top 25 collaborators of Turner Kufe. A scholar is included among the top collaborators of Turner Kufe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Turner Kufe. Turner Kufe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Li, Yin, Turner Kufe, David Avigan, & Donald Küfe. (2014). Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death. Blood. 123(19). 2997–3006. 52 indexed citations

2.

Stroopinsky, Dina, Jacalyn Rosenblatt, Keisuke Ito, et al.. (2013). MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells. Cancer Research. 73(17). 5569–5579. 41 indexed citations

3.

Luptakova, Katarina, Jacalyn Rosenblatt, Brett Glotzbecker, et al.. (2012). Lenalidomide enhances anti-myeloma cellular immunity. Cancer Immunology Immunotherapy. 62(1). 39–49. 132 indexed citations

4.

Yin, Li, Rehan Ahmad, Michio Kosugi, et al.. (2010). Survival of Human Multiple Myeloma Cells Is Dependent on MUC1 C-Terminal Transmembrane Subunit Oncoprotein Function. Molecular Pharmacology. 78(2). 166–174. 26 indexed citations

5.

Stroopinsky, Dina, Jacalyn Rosenblatt, Keisuke Ito, et al.. (2010). Targeting Acute Myeloid Leukemia Stem Cells by MUC1-C Subunit Inhibition. Blood. 116(21). 848–848. 2 indexed citations

6.

Khodarev, Nikolai N., Rehan Ahmad, Hasan Rajabi, et al.. (2009). Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer. Oncogene. 29(6). 920–929. 82 indexed citations

7.

Duraisamy, Sekhar, Turner Kufe, Selvi Ramasamy, & Donald Küfe. (2007). Evolution of the human MUC1 oncoprotein. International Journal of Oncology. 31(3). 671–7. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact